- N-Acetyl-DL-leucine
-
- $0.00 / 1Kg/Bag
-
2025-12-31
- CAS:99-15-0
- Min. Order: 1KG
- Purity: 97.5%-102.5%;AJI88
- Supply Ability: 1000KGS
- N-Acetyl-DL-Leucine
-
- $0.00 / 1kg
-
2025-12-31
- CAS:99-15-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 20MT
- Acetylleucine
-
- $29.00 / 1g
-
2025-12-31
- CAS:99-15-0
- Min. Order:
- Purity: 99.77%
- Supply Ability: 10g
|
| | Acetylleucine Basic information |
| | Acetylleucine Chemical Properties |
| Melting point | 160°C | | Boiling point | 369.7±25.0 °C(Predicted) | | density | 1.069±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | solubility | almost transparency in EtOH | | form | powder to crystal | | pka | 3.67±0.10(Predicted) | | color | White to Almost white | | CAS DataBase Reference | 99-15-0(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 | | HS Code | 29241900 |
| | Acetylleucine Usage And Synthesis |
| Chemical Properties | Colorless solid | | Uses | antivertigo | | Definition | ChEBI: N-acetyl-leucine is a leucine derivative and a N-acetyl-amino acid. | | World Health Organization (WHO) | The products were indicated for the treatment of vertigo and had
been authorized for marketing under the "grandfather" clause, which waives full
registration requirements for products marketed before 1963. | | in vivo | Acetylleucine (60 mg/kg, i.v., on days 1, 2 and 3 after unilateral labyrinthectomy (UL)) accelerates compensation of postural symptoms but not of nystagmus or head roll tilt after UL in rats[3].
|
| | Acetylleucine Preparation Products And Raw materials |
|